학술논문

발행년
-
(예 : 2010-2015)
'학술논문' 에서 검색결과 21건 | 목록 1~10
Academic Journal
Peters AL; Keck School of Medicine of the University of Southern California, Los Angeles, USA.; Buzzetti R; Department of Experimental Medicine, Sapienza University of Rome, Italy.; Lee CJ; Eli Lilly and Company, Indianapolis, USA.; Pavo I; Eli Lilly and Company, Indianapolis, USA.; Liu M; Tigermed-BCM Inc., Somerset, NJ, USA.; Karanikas CA; Eli Lilly and Company, Indianapolis, USA.; Paik JS; Eli Lilly and Company, Indianapolis, USA.
Publisher: Oxford University Press Country of Publication: United States NLM ID: 0375362 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1945-7197 (Electronic) Linking ISSN: 0021972X NLM ISO Abbreviation: J Clin Endocrinol Metab Subsets: MEDLINE
Academic Journal
Grammatikopoulou M; Information Technologies Institute, Centre for Research and Technology Hellas, Thessaloniki, Greece. marggram@iti.gr.; Lazarou I; Information Technologies Institute, Centre for Research and Technology Hellas, Thessaloniki, Greece.; Giannios G; Information Technologies Institute, Centre for Research and Technology Hellas, Thessaloniki, Greece.; Kakalou CA; Institute of Applied Biosciences, Centre for Research and Technology Hellas, Thessaloniki, Greece.; Zachariadou M; Ergobyte SA, Thessaloniki, Greece.; Zande M; Ergobyte SA, Thessaloniki, Greece.; Karanikas H; Department of Computer Science and Biomedical Informatics, University of Thessaly, Lamia, Greece.; Thireos E; Department of Computer Science and Biomedical Informatics, University of Thessaly, Lamia, Greece.; Stavropoulos TG; Information Technologies Institute, Centre for Research and Technology Hellas, Thessaloniki, Greece.; Natsiavas P; Institute of Applied Biosciences, Centre for Research and Technology Hellas, Thessaloniki, Greece.; Nikolopoulos S; Information Technologies Institute, Centre for Research and Technology Hellas, Thessaloniki, Greece.; Kompatsiaris I; Information Technologies Institute, Centre for Research and Technology Hellas, Thessaloniki, Greece.
Publisher: BioMed Central Country of Publication: England NLM ID: 9208826 Publication Model: Electronic Cited Medium: Print ISSN: 0778-7367 (Print) Linking ISSN: 07787367 NLM ISO Abbreviation: Arch Public Health Subsets: PubMed not MEDLINE
Editorial & Opinion
Rosenstock J; Velocity Clinical Research at Medical City, Dallas, Texas, USA.; Lee CJ; Eli Lilly and Company, Indianapolis, Indiana, USA.; Fernández Landó L; Eli Lilly and Company, Indianapolis, Indiana, USA.; Liu M; Tigermed-BDM Inc., Somerset, New Jersey, USA.; Karanikas CA; Eli Lilly and Company, Indianapolis, Indiana, USA.; Thieu VT; Eli Lilly and Company, Indianapolis, Indiana, USA.
Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 100883645 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1463-1326 (Electronic) Linking ISSN: 14628902 NLM ISO Abbreviation: Diabetes Obes Metab Subsets: MEDLINE
Academic Journal
Pedersen SD; C-ENDO Diabetes and Endocrinology Clinic, Calgary, Alberta, Canada.; Giorgino F; Department of Precision and Regenerative Medicine and Ionian Area, Section of Internal Medicine, Endocrinology, Andrology and Metabolic Diseases, University of Bari Aldo Moro, Bari, Italy.; Umpierrez G; Division of Endocrinology, Department of Medicine, Grady Memorial Hospital, Emory University School of Medicine, Atlanta, Georgia, USA.; Thieu VT; Eli Lilly and Company, Indianapolis, Indiana, USA.; Rodríguez A; Eli Lilly and Company, Indianapolis, Indiana, USA.; Nicolay C; Eli Lilly and Company, Indianapolis, Indiana, USA.; Fernández Landó L; Eli Lilly and Company, Indianapolis, Indiana, USA.; Karanikas CA; Eli Lilly and Company, Indianapolis, Indiana, USA.; Kiljanski J; Eli Lilly and Company, Indianapolis, Indiana, USA.
Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 100883645 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1463-1326 (Electronic) Linking ISSN: 14628902 NLM ISO Abbreviation: Diabetes Obes Metab Subsets: MEDLINE
Academic Journal
Pousse L; Roche Pharma Research and Early Development (pRED), Roche Innovation Center Zurich (RICZ), Schlieren, Switzerland.; Korfi K; Roche Pharma Research and Early Development (pRED), Roche Innovation Center Zurich (RICZ), Schlieren, Switzerland.; Medeiros BC; Genentech, Inc. Hematology Department, South San Francisco, CA, United States.; Berrera M; Roche Pharma Research and Early Development (pRED), Roche Innovation Center Basel (RICB), Basel, Switzerland.; Kumpesa N; Roche Pharma Research and Early Development (pRED), Roche Innovation Center Basel (RICB), Basel, Switzerland.; Eckmann J; Roche Pharma Research and Early Development (pRED), Roche Innovation Center Münich (RICM), Penzberg, Germany.; Hutter IK; Roche Pharma Research and Early Development (pRED), Roche Innovation Center Zurich (RICZ), Schlieren, Switzerland.; Griesser V; Roche Pharma Research and Early Development (pRED), Roche Innovation Center Basel (RICB), Basel, Switzerland.; Karanikas V; Roche Pharma Research and Early Development (pRED), Roche Innovation Center Zurich (RICZ), Schlieren, Switzerland.; Klein C; Roche Pharma Research and Early Development (pRED), Roche Innovation Center Zurich (RICZ), Schlieren, Switzerland.; Amann M; Roche Pharma Research and Early Development (pRED), Roche Innovation Center Zurich (RICZ), Schlieren, Switzerland.
Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE
Academic Journal
Heise T; 1Profil, Neuss, Germany.; DeVries JH; 1Profil, Neuss, Germany.; Urva S; 2Eli Lilly and Company, Indianapolis, IN.; Li J; 2Eli Lilly and Company, Indianapolis, IN.; Pratt EJ; 2Eli Lilly and Company, Indianapolis, IN.; Thomas MK; 2Eli Lilly and Company, Indianapolis, IN.; Mather KJ; 2Eli Lilly and Company, Indianapolis, IN.; Karanikas CA; 2Eli Lilly and Company, Indianapolis, IN.; Dunn J; 2Eli Lilly and Company, Indianapolis, IN.; Haupt A; 2Eli Lilly and Company, Indianapolis, IN.; Milicevic Z; 2Eli Lilly and Company, Indianapolis, IN.; Coskun T; 2Eli Lilly and Company, Indianapolis, IN.
Publisher: American Diabetes Association Country of Publication: United States NLM ID: 7805975 Publication Model: Print Cited Medium: Internet ISSN: 1935-5548 (Electronic) Linking ISSN: 01495992 NLM ISO Abbreviation: Diabetes Care Subsets: MEDLINE
Academic Journal
Rosenstock J; Dallas Diabetes Research Center at Medical City, Dallas, TX, USA. Electronic address: juliorosenstock@dallasdiabetes.com.; Wysham C; MultiCare Rockwood Clinic, Spokane, WA, USA.; Frías JP; National Research Institute, Los Angeles, CA, USA.; Kaneko S; Takatsuki Red Cross Hospital, Osaka, Japan.; Lee CJ; Eli Lilly and Company, Indianapolis, IN, USA.; Fernández Landó L; Eli Lilly and Company, Indianapolis, IN, USA.; Mao H; Eli Lilly and Company, Indianapolis, IN, USA.; Cui X; Eli Lilly and Company, Indianapolis, IN, USA.; Karanikas CA; Eli Lilly and Company, Indianapolis, IN, USA.; Thieu VT; Eli Lilly and Company, Indianapolis, IN, USA.
Publisher: Elsevier Country of Publication: England NLM ID: 2985213R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1474-547X (Electronic) Linking ISSN: 01406736 NLM ISO Abbreviation: Lancet Subsets: MEDLINE
Academic Journal
Karanikas E; Department of Psychiatry, 424 General Military Hospital, GR-56429 Thessaloniki, Greece.; II. Department of Psychiatry, Division of Neurosciences, School of Medicine, Aristotle University of Thessaloniki, GR-56430 Thessaloniki, Greece.; Daskalakis NP; Department of Psychiatry, McLean Hospital, Harvard Medical School, Belmont, MA 02478, USA.; Agorastos A; II. Department of Psychiatry, Division of Neurosciences, School of Medicine, Aristotle University of Thessaloniki, GR-56430 Thessaloniki, Greece.; VA Center of Excellence for Stress and Mental Health, VA San Diego Healthcare System, La Jolla, San Diego, CA 92161, USA.
Publisher: MDPI Country of Publication: Switzerland NLM ID: 101598646 Publication Model: Electronic Cited Medium: Print ISSN: 2076-3425 (Print) Linking ISSN: 20763425 NLM ISO Abbreviation: Brain Sci Subsets: PubMed not MEDLINE
Academic Journal
Hartman ML; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN hartman_mark_l@lilly.com.; Sanyal AJ; Division of Gastroenterology, Hepatology and Nutrition, Virginia Commonwealth University, Richmond, VA.; Loomba R; NAFLD Research Center, Department of Medicine, University of California, San Diego, La Jolla, CA.; Division of Gastroenterology, Department of Medicine, University of California, San Diego, La Jolla, CA.; Wilson JM; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN.; Nikooienejad A; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN.; Bray R; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN.; Karanikas CA; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN.; Duffin KL; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN.; Robins DA; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN.; Haupt A; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN.
Publisher: American Diabetes Association Country of Publication: United States NLM ID: 7805975 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1935-5548 (Electronic) Linking ISSN: 01495992 NLM ISO Abbreviation: Diabetes Care Subsets: MEDLINE
Academic Journal
Mayoux M; Cancer Immunotherapy Discovery, Pharmaceutical Research and Early Development, Roche Innovation Center Zurich, Schlieren 8952, Switzerland.; Roller A; Pharmaceutical Sciences, Biomarkers, Bioinformatics and Omics & Pathology, Pharmaceutical Research and Early Development, Roche Innovation Center Basel, Basel 4070, Switzerland.; Pulko V; Cancer Immunotherapy Discovery, Pharmaceutical Research and Early Development, Roche Innovation Center Zurich, Schlieren 8952, Switzerland.; Sammicheli S; Cancer Immunotherapy Discovery, Pharmaceutical Research and Early Development, Roche Innovation Center Zurich, Schlieren 8952, Switzerland.; Chen S; Cancer Immunotherapy Discovery, Pharmaceutical Research and Early Development, Roche Innovation Center Zurich, Schlieren 8952, Switzerland.; Sum E; Cancer Immunotherapy Discovery, Pharmaceutical Research and Early Development, Roche Innovation Center Zurich, Schlieren 8952, Switzerland.; Jost C; Cancer Immunotherapy Discovery, Pharmaceutical Research and Early Development, Roche Innovation Center Zurich, Schlieren 8952, Switzerland.; Fransen MF; Department of Immunohematology and Bloodtransfusion, Leiden University Medical Center, Leiden 2333, Netherlands.; Buser RB; Cancer Immunotherapy Discovery, Pharmaceutical Research and Early Development, Roche Innovation Center Zurich, Schlieren 8952, Switzerland.; Kowanetz M; Oncology Biomarker Development, Genentech Inc., 1 DNA Way, South San Francisco, CA 94080, USA.; Rommel K; Cancer Immunotherapy Discovery, Pharmaceutical Research and Early Development, Roche Innovation Center Zurich, Schlieren 8952, Switzerland.; Matos I; Cancer Immunotherapy Discovery, Pharmaceutical Research and Early Development, Roche Innovation Center Zurich, Schlieren 8952, Switzerland.; Colombetti S; Cancer Immunotherapy Discovery, Pharmaceutical Research and Early Development, Roche Innovation Center Zurich, Schlieren 8952, Switzerland.; Belousov A; Pharmaceutical Sciences, Biomarkers, Bioinformatics and Omics, Pharmaceutical Research and Early Development, Roche Innovation Center Munich, Penzberg 82377, Germany.; Karanikas V; Cancer Immunotherapy Discovery, Pharmaceutical Research and Early Development, Roche Innovation Center Zurich, Schlieren 8952, Switzerland.; Ossendorp F; Department of Immunohematology and Bloodtransfusion, Leiden University Medical Center, Leiden 2333, Netherlands.; Hegde PS; Oncology Biomarker Development, Genentech Inc., 1 DNA Way, South San Francisco, CA 94080, USA.; Chen DS; Product Development, Genentech Inc., 1 DNA Way, South San Francisco, CA 94080, USA.; Umana P; Cancer Immunotherapy Discovery, Pharmaceutical Research and Early Development, Roche Innovation Center Zurich, Schlieren 8952, Switzerland.; Perro M; Cancer Immunotherapy Discovery, Pharmaceutical Research and Early Development, Roche Innovation Center Zurich, Schlieren 8952, Switzerland.; Klein C; Cancer Immunotherapy Discovery, Pharmaceutical Research and Early Development, Roche Innovation Center Zurich, Schlieren 8952, Switzerland.; Xu W; Cancer Immunotherapy Discovery, Pharmaceutical Research and Early Development, Roche Innovation Center Zurich, Schlieren 8952, Switzerland. xu.wei@innoventbio.com.
Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 101505086 Publication Model: Print Cited Medium: Internet ISSN: 1946-6242 (Electronic) Linking ISSN: 19466234 NLM ISO Abbreviation: Sci Transl Med Subsets: MEDLINE
검색 결과 제한하기
제한된 항목
[Author] Karanikas CA
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어